NCT06730347 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06730347
Title	A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Recruitment	Recruiting
Gender	female
Phase	Phase II
Variant Requirements	No
Sponsors	MacroGenics
Indications	endometrial clear cell adenocarcinoma fallopian tube cancer vulva cancer peritoneum cancer ovarian serous carcinoma fallopian tube clear cell adenocarcinoma vaginal cancer cervical clear cell adenocarcinoma ovarian clear cell carcinoma
Therapies	MGD019
Age Groups:	senior \| adult
Covered Countries	USA \| CAN

NCT06730347
Clinical Trial Detail